bromocriptine 0.8 MG Oral Tablet [Cycloset]

RxCUI
859081
RxNorm name
bromocriptine 0.8 MG Oral Tablet [Cycloset]
Display name
bromocriptine 0.8 MG Oral Tablet [Cycloset]
Full name
bromocriptine 0.8 MG Oral Tablet [Cycloset]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CYCLOSETBROMOCRIPTINE MESYLATEAvvisto Therapeutics LLCe42ba916-16b9-4d1c-8d09-9d2fbb1b6c202026-01-12Warnings, Adverse reactionsExact identifier
rxcui: 859081

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20bromocriptine 0.8 MG Oral Tablet [Cycloset]SBD7These highlights do not include all the information needed to use CYCLOSET safely and effectively. See full prescribing information for CYCLOSET. CYCLOSET ® (bromocriptine mesylate tablets), for oral use Initial U.S. Approval: 197820260112
e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20CYCLOSET 0.8 MG Oral TabletPSN7These highlights do not include all the information needed to use CYCLOSET safely and effectively. See full prescribing information for CYCLOSET. CYCLOSET ® (bromocriptine mesylate tablets), for oral use Initial U.S. Approval: 197820260112
e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20Cycloset 0.8 MG Oral TabletSY7These highlights do not include all the information needed to use CYCLOSET safely and effectively. See full prescribing information for CYCLOSET. CYCLOSET ® (bromocriptine mesylate tablets), for oral use Initial U.S. Approval: 197820260112